Michael Gross
Director
Molecular Imaging
Delphinus Medical Technologies, Inc.
United States of America
Biography
Mr. Gross is Managing Director at Beringea, LLC and is responsible for investment sourcing, deal execution and portfolio management, with a focus on healthcare, technology enabled services, and sustainability. He joined the Board of Directors for Delphinus Medical Technologies in 2010. Within the Beringea portfolio of companies, he serves on the boards of Molecular Imaging, InTouch Health, Intervention Insights, Xanitos, Freeosk, and Fiber By-Products, and is a board observer for MedVantx. Previous portfolio companies include Pioneer Surgical Technology (acquired by RTI Biologics), Relume Technology (acquired by Revolution Lighting), and Ecosynthetix (TSX: ECO). Prior to joining Beringea, Mr. Gross was vice president of investment banking with P&M Corporate Finance as well as the investment banking group at Stout Risius Ross, Inc. He is a CFA charterholder and earned a B.A. in Finance from Michigan State University.
Research Interest
Management,Healthcare, Technology,Molecular Imaging
